Martin-Immanuel Bittner | CEO
Arctoris Ltd | United Kingdom

Martin-Immanuel Bittner is a Co-Founder and CEO of Arctoris, the world's first fully automated
cloud lab for drug discovery. He graduated as a medical doctor from the
University of Freiburg in Germany, followed by his DPhil in Oncology as a Rhodes
scholar at the University of Oxford. Martin-Immanuel Bittner has extensive
research experience covering both clinical trials and preclinical drug discovery
and is an active member of several leading cancer research organisations,
including AACR, EACR, ESTRO and EORTC. In recognition of his research
achievements, he was elected a member of the Young Academy of the German
National Academy of Sciences in 2018.